36065614|t|Treatable Ataxias: How to Find the Needle in the Haystack?
36065614|a|Treatable ataxias are a group of ataxic disorders with specific treatments. These disorders include genetic and metabolic disorders, immune-mediated ataxic disorders, and ataxic disorders associated with infectious and parainfectious etiology, vascular causes, toxins and chemicals, and endocrinopathies. This review provides a comprehensive overview of different treatable ataxias. The major metabolic and genetic treatable ataxic disorders include ataxia with vitamin E deficiency, abetalipoproteinemia, cerebrotendinous xanthomatosis, Niemann-Pick disease type C, autosomal recessive cerebellar ataxia due to coenzyme Q10 deficiency, glucose transporter type 1 deficiency, and episodic ataxia type 2. The treatment of these disorders includes the replacement of deficient cofactors and vitamins, dietary modifications, and other specific treatments. Treatable ataxias with immune-mediated etiologies include gluten ataxia, anti-glutamic acid decarboxylase antibody-associated ataxia, steroid-responsive encephalopathy associated with autoimmune thyroiditis, Miller-Fisher syndrome, multiple sclerosis, and paraneoplastic cerebellar degeneration. Although dietary modification with a gluten-free diet is adequate in gluten ataxia, other autoimmune ataxias are managed by short-course steroids, plasma exchange, or immunomodulation. For autoimmune ataxias secondary to malignancy, treatment of tumor can reduce ataxic symptoms. Chronic alcohol consumption, antiepileptics, anticancer drugs, exposure to insecticides, heavy metals, and recreational drugs are potentially avoidable and treatable causes of ataxia. Infective and parainfectious causes of cerebellar ataxias include acute cerebellitis, postinfectious ataxia, Whipple's disease, meningoencephalitis, and progressive multifocal leukoencephalopathy. These disorders are treated with steroids and antibiotics. Recognizing treatable disorders is of paramount importance when dealing with ataxias given that early treatment can prevent permanent neurological sequelae.
36065614	0	17	Treatable Ataxias	Disease	MESH:D001259
36065614	59	76	Treatable ataxias	Disease	MESH:D001259
36065614	92	108	ataxic disorders	Disease	MESH:D001039
36065614	159	190	genetic and metabolic disorders	Disease	MESH:D030342
36065614	208	224	ataxic disorders	Disease	MESH:D001039
36065614	230	246	ataxic disorders	Disease	MESH:D001039
36065614	346	362	endocrinopathies	Disease	MESH:C567425
36065614	423	440	treatable ataxias	Disease	MESH:D001259
36065614	484	500	ataxic disorders	Disease	MESH:D001039
36065614	509	515	ataxia	Disease	MESH:D001259
36065614	521	541	vitamin E deficiency	Disease	MESH:D014811
36065614	543	563	abetalipoproteinemia	Disease	MESH:D000012
36065614	565	595	cerebrotendinous xanthomatosis	Disease	MESH:D019294
36065614	597	624	Niemann-Pick disease type C	Disease	MESH:D052556
36065614	626	663	autosomal recessive cerebellar ataxia	Disease	MESH:D002524
36065614	671	694	coenzyme Q10 deficiency	Disease	MESH:C564403
36065614	696	733	glucose transporter type 1 deficiency	Disease	MESH:C536830
36065614	739	761	episodic ataxia type 2	Disease	MESH:C535506
36065614	912	929	Treatable ataxias	Disease	MESH:D001259
36065614	970	983	gluten ataxia	Disease	MESH:D001259
36065614	1038	1044	ataxia	Disease	MESH:D001259
36065614	1046	1079	steroid-responsive encephalopathy	Disease	MESH:C535841
36065614	1096	1118	autoimmune thyroiditis	Disease	MESH:D013967
36065614	1120	1142	Miller-Fisher syndrome	Disease	MESH:D019846
36065614	1144	1162	multiple sclerosis	Disease	MESH:D009103
36065614	1168	1206	paraneoplastic cerebellar degeneration	Disease	MESH:D020362
36065614	1277	1290	gluten ataxia	Disease	MESH:D001259
36065614	1298	1316	autoimmune ataxias	Disease	MESH:D001259
36065614	1345	1353	steroids	Chemical	MESH:D013256
36065614	1397	1415	autoimmune ataxias	Disease	MESH:D001259
36065614	1429	1439	malignancy	Disease	MESH:D009369
36065614	1454	1459	tumor	Disease	MESH:D009369
36065614	1471	1486	ataxic symptoms	Disease	MESH:D012816
36065614	1496	1503	alcohol	Chemical	MESH:D000438
36065614	1533	1549	anticancer drugs	Chemical	-
36065614	1577	1589	heavy metals	Chemical	MESH:D019216
36065614	1664	1670	ataxia	Disease	MESH:D001259
36065614	1711	1729	cerebellar ataxias	Disease	MESH:D002524
36065614	1744	1756	cerebellitis	Disease	
36065614	1773	1779	ataxia	Disease	MESH:D001259
36065614	1781	1798	Whipple's disease	Disease	MESH:D008061
36065614	1800	1819	meningoencephalitis	Disease	MESH:D008590
36065614	1825	1867	progressive multifocal leukoencephalopathy	Disease	MESH:D007968
36065614	1902	1910	steroids	Chemical	MESH:D013256
36065614	2005	2012	ataxias	Disease	MESH:D001259
36065614	Negative_Correlation	MESH:D013256	MESH:D008061
36065614	Positive_Correlation	MESH:D000438	MESH:D001259
36065614	Association	MESH:D019216	MESH:D001259
36065614	Negative_Correlation	MESH:D013256	MESH:D002524
36065614	Negative_Correlation	MESH:D013256	MESH:D001259
36065614	Negative_Correlation	MESH:D013256	MESH:D008590
36065614	Negative_Correlation	MESH:D013256	MESH:D007968

